Plain-English translation of NCT07188766 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing two different approaches to giving intravenous (IV) fluids to adults with sickle cell disease who are hospitalized with a vaso-occlusive crisis—a sudden, severe pain episode. One approach uses a minimal amount of fluid to keep the IV line open, while the other approach gives a larger amount of fluid upfront followed by ongoing fluids. Researchers want to see if the smaller fluid approach works just as well as the larger approach for relieving pain and getting patients home faster.
Doctors have traditionally given large amounts of IV fluids during sickle cell pain crises, but there's growing evidence that this approach might not always be necessary and could potentially cause harm. This trial aims to find out if giving less fluid—while still keeping patients comfortable and safe—produces the same good results.
You likely qualify if…
You likely don't qualify if…
When you arrive at the emergency department with a pain crisis, you'll be screened for the study and asked to sign a consent form. If you qualify and agree to participate, you'll be randomly assigned to receive either the restricted fluid approach (minimal fluids) or the liberal fluid approach (larger initial fluid amount followed by ongoing fluids). Your assigned fluid regimen will start within the first hour, and the medical team will monitor your pain, how long you stay in the hospital, and other health markers throughout your hospital stay or for up to 28 days after enrollment.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
Saudi Arabia